The KIAA0232 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal cell population derived from the HeLa cell line, engineered for targeted disruption of the KIAA0232 gene. This product provides a loss-of-function model to investigate the uncharacterized KIAA0232 protein, which bioinformatically is predicted to possess endopeptidase activity. The polyclonal format yields a heterogeneous knockout population, avoiding the potential biases of clonal selection and enabling robust assessment of gene function across a diverse cellular background.
HeLa cells, the host line, originate from a cervical epithelial adenocarcinoma and are one of the most extensively used immortalized cell models in biomedical research. They exhibit an HPV18-positive, aneuploid karyotype and rapid proliferation, characteristics that have established HeLa as a benchmark system for cancer biology, virology, and general cell signaling studies. The cervical epithelial origin offers a physiologically relevant context for probing proteins that may influence epithelial carcinogenesis or fundamental cellular processes.
KIAA0232 encodes a protein of unknown function, with in silico analyses suggesting a catalytic core similar to that of endopeptidases. No functional annotation exists beyond this prediction: no upstream regulators, downstream targets, interacting partners, or associated signaling pathways have been identified. The protein has no established disease associations, and its mechanistic role remains entirely unexplored. This deficiency in basic biological knowledge underscores the value of the knockout model as a foundational tool for deorphanizing KIAA0232 and clarifying its potential contributions to proteolytic networks.
Within the HeLa context, disruption of KIAA0232 allows systematic dissection of how loss of a predicted protease impacts cancer cell phenotypes. HeLa cells provide a backdrop of dysregulated proliferation and apoptosis resistance driven by HPV18 oncoproteins, making them suitable for examining whether KIAA0232 participates in processes such as protein quality control, signal peptide maturation, or extracellular matrix remodeling that could modulate malignancy. The polyclonal knockout population enhances detection of consistent biological effects by sampling a range of genetic and epigenetic states, strengthening the reliability of observed phenotypic changes.
These knockout cells are ideally suited for hypothesis-generating functional screens and detailed molecular phenotyping. Recommended experimental approaches include western blotting to verify KIAA0232 depletion (pending availability of specific antibodies), RT-qPCR for transcriptional profiling, proliferation and apoptosis assays to gauge growth and survival impacts, and global discovery techniques such as RNA sequencing and mass spectrometry-based proteomics. By creating a clean loss-of-function background, this model facilitates the discovery of interacting networks and putative substrates linked to the predicted endopeptidase. For inquiries regarding custom knockout services or technical support, contact Ascent Research.
